TXA2R Antibodies

Santa Cruz Biotechnology features a diverse variety of TXA2R monoclonal antibodies for research focused on understanding the thromboxane A2 receptor (TXA2R). TXA2R Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The thromboxane A2 receptor plays a central role in mediating platelet aggregation and vasoconstriction, making it a significant target in cardiovascular research. TXA2R is involved in various physiological and pathological processes, including inflammation and thrombosis, highlighting its importance in understanding cardiovascular diseases. Research focused on TXA2R can provide insights into potential therapeutic targets for managing conditions such as hypertension and atherosclerosis. Scientists can explore the molecular mechanisms and signaling pathways associated with TXA2R function using specific detection methods. Advanced research techniques allow for detailed examination of TXA2R expression patterns and interactions with other molecules. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cardiovascular health and disease mechanisms.